Bayer HealthCare LLC, of Whippany, New Jersey recalls
1 recall recorded since 2018, most recently on 30 April 2026. Status and classification are as published by the CPSC.
Recalls1
Ongoing (FDA)0
Terminated or completed0
Class I (FDA)0
Announced Consumer products
- Recall started
- 30 April 2026
- Reason
- The 6 mL nasal sprays contain an imidazoline, which must be in child-resistant packaging or meet the labeling requirements for non-complying packaging, as required by the Poison Prevention Packaging Act. The 6 mL nasal spray's packaging is not child-resistant nor bears the required labeling statement, posing a risk of serious injury or illness from poisoning, if the contents are swallowed by young children.
- Remedy
- Consumers should immediately secure the recalled bottles out of sight and reach of children and go to the webform posted on www.livewell.bayer.com/afrin-original-spray-recall to begin a request for a refund. Consumers will be asked to take and submit a photo of the product before disposing of it in order to receive a refund.
- Recall number
- 26455
- Travel Size Afrin® Original Nasal Spray 6 mL Bottles
CPSC recall notice
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.